Nutraferon ECOTAZY Injection

In patients with Chronic Kidney Disease (CrCl ≤ 40 mL/min), patients on hemodialysis or peritoneal dialysis, or pediatric/lower-body-weight patients, the kidneys clear Piperacillin and Tazobactam more slowly. The 2.25 g vial provides the exact renal-adjusted dose to eradicate the infection without risking neurotoxicity or drug accumulation.

Many resistant bacteria secrete beta-lactamase enzymes that cleave the penicillin ring of Piperacillin. Tazobactam acts as a "suicide inhibitor" that permanently binds and neutralizes those enzymes, leaving Piperacillin intact to destroy the bacterial cell wall.

Nutraferon ECOTAZY covers Gram-positive cocci, Gram-negative bacilli (including Pseudomonas aeruginosa), and anaerobes (such as Bacteroides), making it effective for polymicrobial infections and urgent empiric therapy before culture results are finalized.

It is typically infused over at least 30 minutes via an intravenous drip, or over 3 to 4 hours when extended-infusion pharmacodynamic protocols are used in intensive care units.

Nutraferon ECOTAZY is contraindicated in patients with a history of penicillin or beta-lactam hypersensitivity. Additionally, if co-administered with IV Vancomycin, renal function (serum creatinine and urine output) must be monitored closely due to additive nephrotoxicity risk.